Daniel A. Carestio is the President and CEO of STERIS plc, having taken over the role in July 2021 after a successful tenure as Chief Operating Officer. With a solid background in operations, Daniel has been integral to STERIS's growth...

Daniel A. Carestio is the President and CEO of STERIS plc, having taken over the role in July 2021 after a successful tenure as Chief Operating Officer. With a solid background in operations, Daniel has been integral to STERIS's growth since he joined the company in 1997. Prior to becoming CEO, he served in various senior leadership positions, including Senior Vice President of Sterilization and Disinfection. His leadership style focuses on performance and aligning company goals with long-term shareholder values. Under his guidance, STERIS has continuously generated increasing cash flows, demonstrating robust financial health. Interestingly, as of 2023, Daniel's total compensation reached approximately $950,776, heavily weighted towards performance-based incentives—which reflects the company's strong performance metrics. Daniel also has a notable track record in insider trading with substantial transactions amounting to millions of dollars, indicating confidence in STERIS’s prospects. He continues to navigate the company through the evolving healthcare landscape, making strategic decisions that shape its future.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other STERIS CEOs

S

Daniel A. Carestio

CEO of STERIS

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

January 1, 1973 - 52 years ago

CEO of STERIS for

3 years 8 months (Jul 2021 - Present)

Previous Experience

Senior Vice President, Sterilization and Disinfection; Senior Vice President, STERIS Applied Sterilization Technologies and Life Sciences

Rivals

Competitors/colleagues of Daniel A. Carestio

Holdings

See how much did Daniel A. Carestio make over time.

Daniel A. Carestio has made significant insider trades totaling millions over the years. In 2021, his holdings peaked with transactions indicating values as high as $19.50 million. These trades highlighted his deep belief in the company's future, mirroring STERIS's expanding...

Daniel A. Carestio has made significant insider trades totaling millions over the years. In 2021, his holdings peaked with transactions indicating values as high as $19.50 million. These trades highlighted his deep belief in the company's future, mirroring STERIS's expanding role in the healthcare sector. As of late 2024, Daniel's holdings value fluctuated from around $7 million to an impressive peak of $33 million. These assets and their swings reflect his confidence in STERIS's market position and growth potential, showing a personal investment in the company's success.

Total Stock Sold

$9.43M

STE

$9.43M

68,017 STE shares

What if they kept their stock?

If Daniel A. Carestio didn't sell their stock, today they would have:
Extra STE68,017 shares worth $10.17M.
This is 7.78% and $734.25K more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Daniel A. Carestio.

STE

12,849 shares

STE

Jun 4, 2024

Received

STE

12,924 shares

STE

May 31, 2023

Received

STE

9,476 shares

STE

Jun 2, 2022

Received

STE

1,156 shares

STE

Oct 1, 2021

Received

STE

6,056 shares

STE

Jun 2, 2021

Received

STE

$2.46M

STE at $182.59/share

Oct 6, 2020

Sale

STE

$2.64M

STE at $175.77/share

Sep 18, 2020

Sale

STE

$1.36M

STE at $169.64/share

Sep 15, 2020

Sale

STE

4,432 shares

STE

Jun 1, 2020

Received

STE

$1.04M

STE at $149.27/share

Aug 7, 2019

Sale

Compensation History

See how much did Daniel A. Carestio make over time.

In 2023, Daniel A. Carestio's total compensation was approximately $950,776, which included a base salary of $1,030,600 and an impressive bonus of $1,123,539 linked directly to performance objectives. Notably, about 87.5% of his total pay is performance-based, aligning his interests with those of shareholders and ensuring he is rewarded for effective management. His previous year's compensation was lower at around $740,184, indicating a significant jump as he adapted to the CEO role. This trend reflects both the increasing responsibilities and the critical role he plays in steering STERIS towards continued success.

Year

2023

Total Compensation

$4.75M

Salary

$1.03M

Board Justification

The compensation philosophy is designed to align management's interests with long-term shareholder value, focusing on performance-based compensation and competitive pay structures.

Bonus

$1.12M

Board Justification

Annual incentive compensation based on performance against financial objectives and individual goals for fiscal 2024, calculated at 87.2% of target bonus opportunity.

Other

$11.99K

Board Justification

Employer matching contributions to the Company 401(k) plan.

Restricted Stock

$2.58M(12.92K Restricted Stock)

Board Justification

Restricted stock awards that vested in fiscal 2024, with a total of 12,924 shares granted.

Performance Metrics

The performance metrics for determining the CEO's compensation include Company-wide financial results and individual performance goals.

Other STERIS CEOs

Here are other CEOs of STERIS

Walter M Rosebrough

Ex-CEO of STERIS

June 2007 - July 2021